ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
188 hedge funds and large institutions have $1.6B invested in Intercept Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 71 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
46% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 48
50% less capital invested
Capital invested by funds: $3.2B → $1.6B (-$1.6B)
Holders
188
Holding in Top 10
3
Calls
$79.6M
Puts
$79.9M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$13.5M | |
| 3 | +$10.7M | |
| 4 |
Barclays
London,
United Kingdom
|
+$10.6M |
| 5 |
Two Sigma Advisers
New York
|
+$9.27M |
Top Sellers
| 1 | -$97M | |
| 2 | -$33.8M | |
| 3 | -$20.9M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$14.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$12.4M |